GlassScriptPhysician profile
Francine Miller
NPI 1013196773
$9,293.40
in general payments reported to CMS, 2019-2025
40 companies · $1,792 in 2025
The $1,792 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,646 · 2022: $936 · 2023: $2,215 · 2024: $2,704 · 2025: $1,792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,711.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,268.05 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,067.61 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $1,000.20 | 2021-2025 | Repatha, Repatha, Otezla |
| Novo Nordisk INC | $935.08 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $676.72 | 2021-2025 | |
| Lilly USA, LLC | $663.67 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| E.R. Squibb & Sons, L.L.C. | $349.73 | 2021-2023 | Camzyos |
| Abbott Laboratories | $262.80 | 2023-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $248.05 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $227.87 | 2022-2024 | Arexvy, Shingrix, Pediarix |
| Janssen Pharmaceuticals, INC | $224.44 | 2021-2025 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $224.20 | 2023-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $201.09 | 2023-2024 | Rexulti, Nuedexta |
| Insmed, INC. | $187.42 | 2021-2023 | Arikayce |
| Bayer Healthcare Pharmaceuticals INC. | $163.60 | 2022-2024 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francine Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.